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Introduction
Metal surfaces are widely used in biomedical devices such
as dental and orthopaedic implants. For example, tita-
nium alloys and metal-on-metal bearings alloys in total
hip arthroplasty are becoming more popular. However,
they can also be colonized by biofilms, leading to
implant-related infections (Hosman et al. 2009), which
are a major financial burden and can be fatal (Oduwole
et al. 2010). The most common bacteria that colonize
implant surfaces are Staphylococcus epidermidis and Staph-
ylococcus aureus (Costerton et al. 1995).
Bacteria adhering to implant surfaces evade host
defences and become more resistant to antibiotics by
forming biofilms (Brady et al. 2008; Kristian et al. 2008;
Otto 2009; Schommer et al. 2011). Bacteria and the host
defence cells compete for the implant surface. If connec-
tive tissue cells colonize first, they form a cell ‘lawn’ that
inhibits bacterial adherence to the surface, protecting the
implant from bacterial colonization. If, however, bacteria
colonize the surface first, they can form a biofilm that is
resistant to host immune cells. This competition between
host cells and bacteria is called ‘the race for surface’
(Gristina 1994).
Improved understanding of the structure of biofilms
and how they function will help to develop treatments to
eliminate biofilms from implant surfaces. In vitro models
of biofilms allow the testing of antimicrobial susceptibility
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Aim: We compared the MBEC-HTP assay plates made of polystyrene with
metal discs composed of TMZF and CrCo as substrates for biofilm formation.
Methods and Results: Staphylococcus aureus was grown on polystyrene and on
metal discs made of titanium and chrome–cobalt. Antibiotic susceptibility was
assessed by examining the recovery of cells after antibiotic exposure and by
measuring the biofilm inhibitory concentration (BIC). The minimal inhibitory
concentration (MIC) was assessed with planktonic cells. Bacterial growth was
examined by scanning electron microscopy. The antibiotic concentration for
biofilm inhibition (BIC) was higher than the MIC for all antibiotics. Micro-
scopic images showed the biofilm structure characterized by groups of cells
covered by a film.
Conclusions: All models allowed biofilm formation and testing with several
antibiotics in vitro. Gentamicin and rifampicin are the most effective inhibitors
of Staph. aureus biofilm-related infections. We recommend MBEC-HTP
assay for rapid testing of multiple substances and TMZF and CrCo discs for
low-throughput testing of antibiotic susceptibility and for microscopic analysis.
Significance and Impact of the Study: In vitro assays can improve the under-
standing of biofilms and help developing methods to eliminate biofilms from
implant surfaces. One advantage of the TMZF and CrCo discs as biofilm
in vitro assay is that these metals are commonly used for orthopaedic implants.
These models are usable for future periprosthetic joint infection studies.
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and the analysis of biofilm architecture and molecular
behaviour. Minimum Biofilm Eradication Concentration–
High Throughput Plate (MBEC-HTP) is an in vitro
model for testing antibiotic susceptibility of biofilms
(Moskowitz et al. 2004). This system allows several sub-
stances to be tested at the same time. Other models have
been developed using intraocular lenses (Okajima et al.
2006), central venous catheters (Gaonkar and Modak
2003), bone grafts substitutes and metal surfaces (Clauss
et al. 2010; Wanner et al. 2011) as substrates. Because
TMZF (TiMo12Zr6Fe2) and CrCo (Vitallium-
CoCr30Mo5) are used to manufacture knee and hip pros-
thesis, they could also be used to develop in vitro biofilm
models, although biofilm growth on TMZF and CrCo
has not been previously examined.
In this study, we investigated whether biofilms grow in
vitro on TMZF and CrCo discs and on the MBEC-
HTP assay. The evaluation of the biofilms formed on dif-
ferent surfaces was assessed by comparing the antibiotic
susceptibility of Staph. aureus and by examining the
structure of Staph. aureus biofilms grown by scanning
electron microscopy (SEM). We used Staph. aureus ATCC
29213 in this study because it has been previously
shown to be a good biofilm former and produces mature




American Type Culture Collection Staph. aureus (ATCC
29213) was used in this study (Ceri et al. 1999; DeRyke
et al. 2006). For the preparation of the inoculums, the
lyophilized strains were freshly grown overnight on
Mu¨ller–Hinton (MH) agar plates (Sigma-Aldrich, Hamburg,
Germany). Discrete colonies were obtained from MH
agar plates and resuspended in MH broth to a McFarland
turbidity of 0Æ5.
Substrates for biofilm formation
MBEC-HTP assay plates (Ceri et al. 1999) made of polysty-
rene were purchased from Innovotech (Edmonton, Alberta,
Canada). TMZF a titanium alloy (TiMo12Zr6Fe2) discs
(Koban et al. 2011) and CrCo a chrome–cobalt–molybde-
num alloy (Vitallium-CoCr30Mo5) discs (Hosman et al.
2009), usually employed for joint replacement implants
confection, were purchased from Stryker GmbH & Co KG
(Duisburg, Germany). Each peg of the MBEC-HTP plates
had an area of 130 mm2, while each TMZF and CrCo disc
had an area of 157 mm2.
Antibiotics
Gentamicin and rifampicin were purchased from SERVA
GmbH (Heidelberg, Germany), vancomycin from Astro
Pharma (Vienna, Austria), fosfomycin from BioChemika-
Fluka (Buchs, Switzerland), and clindamycin as well as
linezolid from Pfizer (Vienna, Austria). For the antibiotic
susceptibility tests, we chose the substances usually indi-
cated for treatment of periprosthetic joint infections or
for Staph. aureus infections (Raad et al. 1995; Anguita-
Alonso et al. 2005; Buttaro et al. 2005; Trampuz and
Zimmerli 2005; Colli et al. 2007; Teller et al. 2007; Ensing
et al. 2008; Fujimura et al. 2008; Schiefer et al. 2008;
Swieringa et al. 2008; Michalopoulos et al. 2011; Nadrah
and Strle 2011; Corac¸a-Huber et al. 2012; Tang et al.
2012).
Minimum inhibitory concentration (MIC)
The MIC was determined for each antibiotic by placing
Etest strips (Biome´rieux, Marcy L’Etoile, France) (Rennie
et al. 2012) on MH agar plates inoculated with
Staph. aureus (ATCC 29213) for 24 h at 37C. Assays
were carried out in triplicate.
Biofilm formation and antibiotic susceptibility tests for
Staphylococcus aureus grown in the MBEC-HTP assay
Two millilitres of 2 · 105 CFU ml)1 of Staph. aureus was
added to each MBEC-HTP plate. The plates were cov-
ered and incubated at 37C for 48 h on a rocking table at
12 cycles min)1. For antibiotic susceptibility tests, after
48 h, the lids were removed from the MBEC-HTP
plates, rinsed in saline solution for 1 min to remove the
planktonic cells, added to challenge plate containing
100 ll per well of antibiotics dilutions in MH broth (1,
32 or 256 lg ml)1) and incubated at 37C for 24 h. The
challenge plates were removed from the incubator, and
the lids containing biofilms were rinsed in saline solution
for 1 min and placed on a new 96-well plate containing
MH broth without antibiotics (recovery plate). To detach
the biofilms from the pegs in the lid, the recovery plates
were placed in a sonicator (Transsonic 570 Elma,
Singen, Germany) and sonicated for 5 min on the high set-
ting. The MBEC-HTP lids were removed and replaced
with a conventional microtitre plate lid, and the recovery
plates were incubated at 37C for 24 h. After 2 and 5 h
(Corac¸a-Huber et al. 2012), 10 ll of suspended cells was
transferred from each well to individual MH agar plates.
After 24 h at 37C, colony-forming units (CFU) were
counted. Results from 5 h were used to determine the bio-
film inhibitory concentration (BIC), which was considered
the lowest concentration of antibiotic that resulted in no
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bacterial growth. All experiments were carried out in
triplicate, and all antibiotic concentrations were tested in
triplicate.
Biofilm formation and antibiotic susceptibility tests for
cells grown for Staphylococcus aureus grown on TMZF
and CrCo discs
TMZF and CrCo discs were sterilized in an autoclave
and placed in 15-ml Falcon tubes (Becton, Dickinson and
Company, Franklin Lakes, NJ, USA) containing MH
broth inoculated with 2 · 105 CFU ml)1 of Staph. aureus
(ATCC 29213). The tubes containing the discs were incu-
bated at 37C for 48 h on a rocking table at 12 cycles -
min)1. After 48 h, the discs were removed from the
original tubes, rinsed in saline solution for 1 min to
remove the planktonic cells, added to tubes containing
2 ml of antibiotic (1, 32 or 256 lg ml)1) and incubated
at 37C for 24 h.
For antibiotic susceptibility assays, after 24 h, the discs
were removed from the tubes containing antibiotics,
rinsed in saline solution for 1 min and added to new
tubes containing MH broth without antibiotics. To
detach the biofilms from the discs, the recovery tubes
were placed in a sonicator (Transsonic 570 Elma) and
sonicated for 5 min on the high setting. The discs were
then removed, and the tubes were incubated at 37C.
After 2 and 5 h, 10 ll of each sample was transferred to a
MH agar plate. After 24 h at 37C, CFU were counted.
Results from 5 h were used to determine the BIC, which
was considered the lowest concentration of antibiotic that
resulted in no bacterial growth. All experiments were car-
ried out in triplicate, and all antibiotic concentrations
were tested in triplicate.
Scanning electron microscopy (SEM)
For bacteria grown in the MBEC-HTP assay, the pegs
were removed from the lids with flamed pliers and rinsed
in saline solution for 1 min to remove planktonic cells.
For bacteria grown on TMZF and CrCo discs, the discs
were rinsed in saline solution for 1 min. Pegs and discs
were fixed with 2Æ5% glutaraldehyde (BioChemika Fluka)
in 0Æ1 mol l)1 phosphate buffer (pH 7Æ4) before and after
antibiotic treatment. After a brief wash in phosphate buf-
fer, followed by postfixation for 1 h with 1% aqueous
osmium tetroxide (ReagentPlus; Sigma-Aldrich), samples
were gradually dehydrated with ethanol. After critical-
point drying (CPD 030, Bal-Tec), specimens were
mounted on aluminium stubs with double-sided adhesive
tape, sputter-coated with 10-nm Au ⁄Pd (Bal-Tec) and
examined with a field emission scanning electron micro-
scope (Gemini 982; Zeiss, Goettingen, Germany).
Statistical analysis
Statistical comparisons were made by Spearman nonpara-
metric correlations. A P-value below 0Æ05 was considered
statistically significant. All calculations were made using
spss version 17 (SPSS Inc., Chicago, IL, USA).
Results
Biofilm formation on MBEC-HTP, TMZF and CrCo
surfaces
The CFU counting from biofilms formed on the different
surfaces without antibiotic treatment showed the presence
of more cells on the TMZF and CrCo discs compared to
MBEC-HTP after 2-h incubation. After 5 h, the num-
ber of CFU was equal on both surfaces. On the MBEC-
HTP peg surfaces, the number of CFU was 3Æ9log10 after
2-h incubation and 7Æ0log10 after 5-h incubation. The CFU
counting from biofilms formed on TMZF and CrCo
discs were similar for both surfaces with 6Æ0log10 after 2 h
and 7Æ0log10 after 5 h (Figs 1 and 2).
Antibiotic susceptibility of Staphylococcus aureus grown
on MBEC-HTP plates and on TMZF and CrCo discs
We first examined the antibiotic sensitivity of Staph. aur-
eus grown on MBEC-HTP and on TMZF and CrCo
discs by assessing the recovery after exposure to several
antibiotics. For cells grown in MBEC-HTP assays, recov-
ery was the slowest following exposure to gentamicin and
rifampicin. The concentrations of 32 and 256 lg ml)1 of
gentamicin and rifampicin showed better efficacy when
compared with 1 lg ml)1 after 2 and 5 h. For cells grown
on TMZF discs, recovery was the slowest following expo-
sure to vancomycin, and for cells grown on CrCo discs,
recovery was the slowest following exposure to both genta-
micin and vancomycin. In these cases, the concentrations
of 32 and 256 lg ml)1 also showed better efficacy after 2-
and 5-h incubation when compared with 1 lg ml)1. These
findings indicate that gentamicin and rifampicin are the
most potent antibiotics against Staph. aureus grown on
MBEC-HTP, vancomycin against cells grown on
TMZF, and gentamicin and vancomycin against cells
grown on CrCo discs (Figs 1 and 2).
Scanning electron microscopy
SEM revealed extensive cell attachment on the MBEC-
HTP peg surface (Fig. 3a). A three-dimensional structure
is visible with deep layers of bacteria surrounded by
an amorphous matrix in some areas (Fig. 3b). Similar
biofilm structures can be observed on the TMZF surface.
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Also, an agglomeration of cells is visible in some areas
of the biofilm (Fig. 3c), and some of these are covered
by a film or granule-like elements (Fig. 3d). A well-
structured biofilm can be seen on the CrCo disc surface
(Fig. 3e), with a three-dimensional structure covered by
a matrix-like film and occasional channels between the
cells (Fig. 3f). The biofilm structure observed on
MBEC-HTP was similar to the structure observed on
TMZF surfaces. On CrCo discs, the biofilm structure
was more island-like when compared to MBEC-HTP
and TMZF surfaces that showed biofilms covering
bigger areas.
Comparison of antibiotic sensitivity of Staphylococcus
aureus grown on the MBEC-HTP assay, TMZF and
CrCo discs and Staphylococcus aureus grown in
planktonic cultures
We next examined the sensitivity of Staph. aureus grown
in the biofilm systems and in planktonic cultures to gen-
tamicin, vancomycin, rifampicin, fosfomycin, clindamycin
and linezolid (Table 1). Irrespective of the antibiotic
tested, the MICs for planktonic cultures were £2 lg ml)1.
In contrast, the BICs were above the maximum concen-












































































































r = 0·747;P = 0·005
r = 0·792;P = 0·002 *
r = 0·849;P < 0·001
r = 0·824;P = 0·001
r = 0·892;P < 0·001 **
































Figure 1 Antibiotic susceptibility of Staphylococcus aureus grown on MBEC-HTP plates, TMZF and CrCo discs. Staphylococcus aureus were
grown on MBEC-HTP plates and on TMZF and CrCo discs for 48 h and incubated with 1, 32 or 256 lg ml)1 of the indicated antibiotics for
24 h. The media were replaced with antibiotic-free media, and CFU were counted after 2 h. The correlation between most potent antibiotics (all
concentrations) for each method used for biofilm formation is indicated as r = (correlation coefficient) and P = (significance). Threshold: min = 1 -
CFUlog10 and max = 7 CFUlog10. Each test was carried out in triplicate. ( ) Control; ( ) 1 lg ml
)1; ( ) 32 lg ml)1 and ( ) 256 lg ml)1.
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the TMZF disc assay and 256 lg ml)1 in all other cases).
However, all antibiotics inhibited the bacterial growth to
some extent (data not shown). These results show that
the BIC was higher than the MIC for all antibiotics.
Discussion
In this study, we compared the MBEC-HTP assay and
TMZF and CrCo discs as models for biofilm formation
in vitro. We found that biofilms were formed in all three
systems. Each system provided different advantages and
disadvantages, although all three models allowed estima-
tion of the BIC.
For the antibiotic susceptibility tests, we chose the sub-
stances usually indicated for treatment of periprosthetic
joint infections or for Staph. aureus infections. The sub-
stances used were gentamicin (Anguita-Alonso et al. 2005;















































































































































Figure 2 Antibiotic susceptibility of Staphylococcus aureus grown on MBEC-HTP plates, on TMZF and CrCo discs. Staphylococcus aureus were
grown on MBEC-HTP plates and on TMZF and CrCo discs for 48 h and incubated with 1, 32 or 256 lg ml)1 of the indicated antibiotics for
24 h. The media were replaced with antibiotic-free media, and CFU were counted after 5 h. The correlation between most potent antibiotics (all
concentrations) for each method used for biofilm formation is indicated as r = (correlation coefficient) and P = (significance). Threshold: min = 1 -
CFUlog10 and max = 7 CFUlog10. Each test was carried out in triplicate. ***Correlation between MBEC-HTP and TMZF (r = 0Æ775; P = 0Æ003),
between MBEC-HTP and CrCo (r = 0Æ860; P < 0Æ001) and between TMZF and CrCo (r = 0Æ915; P < 0Æ001). ( ) Control; ( ) 1 lg ml)1; ( )
32 lg ml)1 and ( ) 256 lg ml)1.
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2011), vancomycin (Buttaro et al. 2005; Fujimura et al.
2008), rifampicin (Raad et al. 1995; Trampuz and Zimm-
erli 2005; Corac¸a-Huber et al. 2012), fosfomycin (Micha-
lopoulos et al. 2011; Tang et al. 2012), clindamycin
(Ensing et al. 2008; Schiefer et al. 2008) and linezolid
(Colli et al. 2007). The incubation periods chosen to
evaluate the efficacy of the antibiotic substances in this
study were 2 and 5 h. A previous study carried out by our
team showed that the number of CFU after 24 h of incu-
bation with all antibiotics extrapolated the threshold of
7 CFUlog10. For this reason, we exclude the period of 24-h
incubation from this study (Corac¸a-Huber et al. 2012).
SEM images of the biofilms obtained in all three mod-
els showed groups of cells embedded in an amorphous
substance. In all cases, the cells had a similar organization
and an amorphous structure covering the cells. Such an
amorphous structure around bacteria and clumps of bac-
teria embedded in a dense matrix is considered character-
istic of a biofilm (Nickel et al. 1985; Walsh et al. 1986;
Henry-Stanley et al. 2010). The differences found between
BIC and MIC in our study further support the fact that
the cells developed some kind of resistance against the
antibiotics, which could also indicate biofilm formation.
The BIC and MIC would be similar if only cumulative
planktonic cells were present, and the lower antibiotic
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Figure 3 SEM of cells grown on MBEC-HTP plates (a, b), TMZF discs (c, d) and CrCo disc (e, f). Cells were grown for 48 h. Magnification =
200· (a), 500· (b, c, e), 5000· (d), and 20 000· (f).
Table 1 Comparison of MICs and BICs for Staphylococcus aureus








Gentamicin 0Æ25 >256 >32 >256
Vancomycin 1Æ00 >256 >256 >256
Rifampicin <0Æ016 >256 >256 >256
Fosfomycin 1Æ00 >256 >256 >256
Clindamycin 0Æ094 >256 >256 >256
Linezolid 2Æ00 >256 >256 >256
MICs, minimal inhibitory concentration; BICs, biofilm inhibitory
concentration.
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suggests the presence of a protective extracellular matrix,
in agreement with the SEM findings.
Antibiotic sensitivity tests showed that gentamicin was
the most potent substance against Staph. aureus biofilms.
Independent of model or time of incubation, gentamicin
was able to eradicate more bacteria than the other antibi-
otics tested. For the biofilms grown on MBEC-HTP
plates, in addition to gentamicin, rifampicin showed high
potency against biofilms. For the biofilms grown on
TMZF and the CrCo discs, gentamicin, vancomycin and
also fosfomycin showed high potency against Staph. aur-
eus (ATCC 29213) biofilms. The differences in the efficacy
of vancomycin and fosfomycin observed between the
methods could be due to the surface area of the different
substrates. TMZF and the CrCo discs have more area
for the growth of the biofilms compared to the MBEC-
HTP pegs. Apart from the difference in surface area of
the substrates, the surface structure could also be a reason
for differences in the efficacy of the antibiotics. Topo-
graphical features can influence the arrangement and the
resulting behaviour of cells on surfaces and may affect
biofilm growth. However, the roles of specific surface
structures in modifying bacterial attachment and
subsequent behaviour remain unclear (Hochbaum and
Aizenberg 2010; Epstein et al. 2011).
For the control groups, the number of CFU obtained
from biofilms formed on the discs after 2 h of incubation
was two times higher than the CFU obtained from
MBEC-HTP plates. This could explain the difference in
efficacy between some antibiotics, as observed for vanco-
mycin and fosfomycin. The efficacy of gentamicin, rifam-
picin, vancomycin (Joosten et al. 2005; Kotulova and
Slobodnikova 2010; Michalopoulos et al. 2011) and fosfo-
mycin (Tang et al. 2012) against Staph. aureus biofilms
was also described by other researchers in previous works.
The MBEC-HTP plates allowed us to obtain biofilms
and to rapidly and easily test several antibiotics. However,
we modified the procedure for detaching the biofilms.
According to the manufacturer, the plates should be
placed inside the sonicator without any water contact,
which contradicts the sonication principles which say that
water is necessary for the propagation of the acoustic
impulse and detachment of the biofilm from the pegs.
Contact of the MBEC-HTP plates with the water of the
sonicator, even after sealing the plates, increases the risk
of contamination. Therefore, unlike Ceri et al. (1999), we
think that the MBEC-HTP plates may have some limi-
tations for studying biofilms in vitro. In addition, for
SEM, the MBEC-HTP pegs must be removed from the
plates using pliers, which is difficult. This could also dis-
turb the biofilm structure, and it increases the risk of
contamination. This could decrease the accuracy of
the microscopic analysis. The risk of contamination or
damage is less with TMZF and CrCo discs because less
manipulation is needed.
All three models were effective for biofilm formation
and testing. The MBEC-HTP assay has the advantage
of high throughput. One disadvantage of this system was
observed during the sonication process. This step could
increase the risks of contamination since the plates are
not adapted to an ultrasonic bath and even after sealing
them some water could reach the interior. Therefore,
we recommend the MBEC-HTP assay for tests involv-
ing several antibiotics or other substances and the
TMZF and CrCo discs for low-throughput antibiotic
susceptibility tests and for microscopic analysis. Finally,
the findings suggest that gentamicin and rifampicin are
good choices for treating Staph. aureus biofilm-related
infections.
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